Oct 22, 2025
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
Read More
Oct 6, 2025
AtaCor Medical Secures $75M Financing to Support the Pivotal U.S. Study of its Extravascular ICD (EV-ICD) System
Read More
Sep 18, 2025
Cardiosense Appoints Eric Meizlish as CEO to Advance AI-Enabled Cardiac Care
Read More
Sep 4, 2025
Edwards buys remaining stake of Vectorious Medical Technologies and its heart implant
Read More
Aug 12, 2025
Cardiosense Appoints Medtech Executive John Martin, MD as EVP and Chief Medical Officer
Read More
Jul 30, 2025
Cardiosense Receives FDA 510(k) Clearance for the CardioTag™ Device, Paving the Way for Advanced Cardiac Function Monitoring
Read More
1234567